{"nctId":"NCT04311697","briefTitle":"Intravenous Aviptadil for Critical COVID-19 With Respiratory Failure","startDateStruct":{"date":"2020-05-15","type":"ACTUAL"},"conditions":["Critical COVID-19 With Respiratory Failure","Acute Respiratory Distress Syndrome (ARDS)","Corona Virus Infection","Acute Lung Injury"],"count":203,"armGroups":[{"label":"Aviptadil IV in escalating doses + standard of care","type":"EXPERIMENTAL","interventionNames":["Drug: Aviptadil by intravenous infusion + standard of care"]},{"label":"Placebo + standard of care","type":"EXPERIMENTAL","interventionNames":["Drug: Normal Saline Infusion + standard of care"]}],"interventions":[{"name":"Aviptadil by intravenous infusion + standard of care","otherNames":["ZYESAMI (aviptadil) +SOC"]},{"name":"Normal Saline Infusion + standard of care","otherNames":["Placebo+SOC"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Critical COVID-19 with respiratory failure\n* Physician determination that patient is on maximal conventional medical therapy\n\nExclusion Criteria:\n\n1. Pregnancy (pregnant women may apply for open label treatment under compassionate care IND\n2. Age \\<18 years\n3. Mechanical ventilation for more than 7 days in primary cohort. Mechanical ventilation\\>21 days in the exploratory cohort\n4. Mean Arterial Pressure \\< 65 mm Hg with use of pressor per ICU protocol\n5. Irreversible condition (other than COVID-19) with projected fatal course\n6. ECMO\n7. Current or recent (within 30 d) enrollment in another investigational trial of anti-IL6 drug;\n8. Active diagnosis of Acquired immune deficiency syndrome;\n9. Transplant patients currently immunosuppressed;\n10. Chemotherapy-induced neutropenia (granulocyte count \\<1000/mm3);\n11. Cardiogenic shock; congestive heart failure - NYHA Class 3 or 4;\n12. Recent myocardial infarction - within last 6 months and troponin \\> 0.5\n13. Anuria (urine output \\< 50 ml/d) or other signs of multi-organ failure\n14. Severe liver disease with portal hypertension;\n15. Recent stroke or head trauma within last 12 months\n16. Increased intracranial pressure, or other serious neurologic disorder;\n17. Liquid Diarrhea more than 3x/day; defined as more than 3 non-bloody watery stools within a 24-hour period, requiring additional fluid and electrolyte supplementation","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"100 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Resolution of Respiratory Failure (Alive and Free of Respiratory Failure)","description":"Participant is Alive and Free of Respiratory Failure (without subsequent relapse over 7 days) determined as no longer requiring acute care or more than low flow oxygen","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"72","spread":null},{"groupId":"OG001","value":"33","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants Alive at Day 60","description":"Survival probability on logistic regression through day 60","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"85","spread":null},{"groupId":"OG001","value":"35","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants Achieving a Score of 6-8 on NIAID Ordinal Score Through Day 60","description":"Achievement of score 6-8 on NIAID Ordinal Scale through day 60 The NIAID score is the patient's status on the following 8-point scale:1)Death2)Hospitalized, on invasive mechanical ventilation or extracorporeal membrane oxygenation (ECMO),3)Hospitalized, on non-invasive ventilation or high flow oxygen devices4)Hospitalized, requiring supplemental oxygen5)Hospitalized, not requiring supplemental oxygen - requiring ongoing medical care (COVID-19 related or otherwise)6)Hospitalized, not requiring supplemental oxygen - no longer requires ongoing medical care7)Not hospitalized, limitation on activities and/or requiring home oxygen8)Not hospitalized, no limitations on activities-- a lower NIAID score is a worse outcome.","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"76","spread":null},{"groupId":"OG001","value":"35","spread":null}]}]}]},{"type":"SECONDARY","title":"Oxygenation Index as Measured by PaO2:FiO2 Ratio","description":"oxygenation index (also known as Respiratory Distress Ratio) as measured by PaO2:FiO2 ratio (Respiratory Distress while on mechanical ventilation). RDR: PaO2:FiO2 represents an intermediate clinical endpoint that is known to be predictive of survival. RDR can only be measured in patients on mechanical ventilation because of its reliance on arterial blood gas measurements that are not routinely collected in non-intubated patients. A higher score indicates a better clinical outcome.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"139.2","spread":"77.0"},{"groupId":"OG001","value":"116.2","spread":"41.77"}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Change in IL-6","description":"Change in IL-6, an inflammatory marker","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"19.8","spread":"39.9"},{"groupId":"OG001","value":"23.5","spread":"39.7"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":58,"n":131},"commonTop":["hypotension","diarrhoea","acute kidney injury","COVID-19","deep vein thrombosis"]}}}